Providence Medical Technology Secures $25 Million In Equity Financing - Providence Medical Technology, Inc.

Providence Medical Technology, Inc., an innovator in tissue-sparing surgical equipment and implants for cervical spine fusion surgery, today announced the closing of $25 million in new equity financing. The proceeds of the financing will be used to accelerate commercial expansion and clinical development of its DTRAX® line of cervical fusion instruments designed to help patients suffering from advanced cervical spine conditions.

Team | Innovation | Quality | Passion | Transparency
Copyright © 2024, Providence Medical Technology. All rights reserved.